Additionally, the report highlights the termination of the Option Care Health, Inc. ("OPCH") Merger Agreement and the ...

Gain insights into Chemed Corporation's Q1 2025 performance, with VITAS growth, strategic Medicare Cap solutions, and Roto-Rooter's revenue recovery outlined.

Amedisys (Nasdaq: AMED) exceeded Wall Street expectations in its first-quarter results for 2025. The company’s home health segment benefited from ...

U.S. crude oil inventories rose for a fourth consecutive week amid higher net imports, while refineries ramped up their capacity use. Commercial crude oil stocks excluding the Strategic Petroleum ...

SBA loans are small-business loans offered by banks and online lenders and partly guaranteed by the government. Check SBA loan rates for 2025SBA loans offer some of the lowest rates on the market ...

In a report released today, Matt Larew from William Blair maintained a Hold rating on Amedisys (AMED – Research Report). The company’s shares ...

Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...

Headwinds primarily associated with Medicare Advantage (MA) and care activity in its insurance business led UnitedHealth Group (UHG) (NYSE: UNH) to lower ...

Amedisys (AMED) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stock markets surged in response after several days of significant declines. Business leaders across the spectrum, from Bill Ackman to Mark Cuban, reacted disparately. President Donald Trump on ...

President Donald Trump announced a complete three-month pause on all the “reciprocal” tariffs that went into effect at midnight, with the exception of China, a stunning reversal from a ...